September 26, 2024 09:00 PM EDT
Startups
Special

End­points 11 win­ner MediLink Ther­a­peu­tics: Chi­na start­up helps pow­er the ADC re­nais­sance

Amber Tong

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ex­clu­sive: FDA's Makary sought re­jec­tion of KalVista’s drug in an un­usu­al move by com­mis­sion­er, sources say

Up­dat­ed: Am­gen plans low­er, slow­er Mar­i­Tide dos­es for obe­si­ty drug’s Phase 3

Rev­o­lu­tion inks up to $2B 'flex­i­ble' fund­ing deal to ad­vance RAS in­hibitor pipeline

Nek­tar's mid-stage eczema da­ta de­liv­er key win in bid for com­pa­ny turn­around

Nu­va­lent clos­es in on FDA fil­ing for lung can­cer drug with topline Phase 1/2 da­ta

sponsored

Dig­i­tal Twins in GMP Man­u­fac­tur­ing: Shap­ing the Fu­ture of CPV with Aizon

A service from the Financial Times